Doctor profile · Federal record
Dr. PARITA VASA, MD
Rheumatology Physician (CMS: RHEUMATOLOGY) · Student in an Organized Health Care Education/Training Program · MANASSAS, VA
- NPI 1588810071
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 22 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
8100 ASHTON AVE, SUITE 215
MANASSAS, VA 201095622
(703) 361-3255
fax (703) 361-6990
Credentials & registration
- NPI registered
- August 2008 — 18 yrs on file
- Profile last updated
- August 9, 2010
- Year of graduation
- 2004 — 22 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Virginia #0101247661
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1588810071. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
10,039
Distinct HCPCS
10
Medicare allowed
$339,765
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 8,640 | 89 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 554 | 357 | $127 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 190 | 40 | $73 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 124 | 82 | $177 | |
96372 |
Injection of drug or substance under skin or into muscle | 116 | 83 | $14 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 88 | 13 | $131 | |
J3489 |
Injection, zoledronic acid, 1 mg | 85 | 17 | $9 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 78 | 63 | $90 | |
77080 |
Dxa bone density measurement of hip, pelvis, spine | 61 | 60 | $38 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 37 | 37 | $166 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 5,923. This provider delivers 1.7× the peer median.Open Payments
Industry payments received
All-time total
$715
Transactions
28
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 10 | $275.66 | |
| Novartis Pharmaceuticals Corporation | 5 | $113.48 | |
| Janssen Biotech, Inc. | 4 | $112.05 | |
| ANI Pharmaceuticals, Inc. | 3 | $69.41 | |
| Lilly USA, LLC | 2 | $48.49 | |
| Amgen Inc. | 2 | $43.83 | |
| DePuy Synthes Sales Inc. | 1 | $30.47 | |
| Aurinia Pharma U.S., Inc. | 1 | $21.91 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,471
Patients
385
Total drug cost
$239,659
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 394 | 117 | $25,116 |
| Methotrexate (Methotrexate Sodium) | Brand | 290 | 81 | $12,107 |
| Prednisone | Generic | 188 | 62 | $1,173 |
| Alendronate Sodium | Generic | 168 | 50 | $1,866 |
| Sulfasalazine | Generic | 81 | 21 | $1,182 |
| Folic Acid | Generic | 55 | 16 | $262 |
| Duloxetine Hcl | Generic | 51 | 16 | $1,631 |
| Cyclobenzaprine Hcl | Generic | 39 | 0 | $299 |
| Meloxicam | Generic | 36 | 11 | $303 |
| Leflunomide | Generic | 34 | 0 | $1,106 |